G. Höll

Imaging-based target volume reduction in chemoradiotherapy for locally advanced non-small-cell lung cancer (PET-Plan): a multicentre, open-label, randomised, controlled trial

Ursula Nestle, Tanja Schimek‐Jasch, Stephanie Kremp et al. · The Lancet Oncology · 2020 · 169 citations

Engineering, Oncologic Imaging, Medical Imaging +9

Validation of sentinel lymph node dissection in prostate cancer: experience in more than 2,000 patients

G. Höll, R. Dorn, H. Wengenmair et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2009 · 135 citations

Surgical Oncology, Urology, Medicine +5

Limitations of Radioguided Surgery in High-Risk Prostate Cancer

Dorothea Weckermann, R. Dorn, G. Höll et al. · European Urology · 2006 · 92 citations

Urology, Surgical Oncology, Radiation Therapy +5

Reliability of preoperative diagnostics and location of lymph node metastases in presumed unilateral prostate cancer

Dorothea Weckermann, G. Höll, R. Dorn et al. · British Journal of Urology · 2007 · 40 citations

Neoadjuvant chemotherapy affects staging of colorectal liver metastasis—a comparison of PET, CT and intraoperative ultrasound

Johann Spatz, G. Höll, J. Sciuk et al. · International Journal of Colorectal Disease · 2010 · 30 citations

Surgical Oncology, Hepatology, Neoadjuvant Chemotherapy +14